English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 126 | Tables: 244 | Medical Care
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results
The global market for Cryopreserved Hepatocytes was estimated to be worth US$ 565 million in 2023 and is forecast to a readjusted size of US$ 797.4 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
North American market for Cryopreserved Hepatocytes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cryopreserved Hepatocytes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Cryopreserved Hepatocytes was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Cryopreserved Hepatocytes include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA, Cytes Biotechnologies, BioIVT, XenoTech, Sunncell and Atlantis Bioscience Pte Ltd, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cryopreserved Hepatocytes, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cryopreserved Hepatocytes by region & country, by Type, and by Application.
The Cryopreserved Hepatocytes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cryopreserved Hepatocytes.
Market Segmentation
By Company
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Segment by Type:
Human Hepatocytes
Animal Liver Cells
Segment by Application
Cell/Molecular Biology
Virology
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cryopreserved Hepatocytes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cryopreserved Hepatocytes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cryopreserved Hepatocytes in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Cryopreserved Hepatocytes Product Introduction
1.2 Global Cryopreserved Hepatocytes Market Size Forecast
1.2.1 Global Cryopreserved Hepatocytes Sales Value (2019-2030)
1.2.2 Global Cryopreserved Hepatocytes Sales Volume (2019-2030)
1.2.3 Global Cryopreserved Hepatocytes Sales Price (2019-2030)
1.3 Cryopreserved Hepatocytes Market Trends & Drivers
1.3.1 Cryopreserved Hepatocytes Industry Trends
1.3.2 Cryopreserved Hepatocytes Market Drivers & Opportunity
1.3.3 Cryopreserved Hepatocytes Market Challenges
1.3.4 Cryopreserved Hepatocytes Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cryopreserved Hepatocytes Players Revenue Ranking (2023)
2.2 Global Cryopreserved Hepatocytes Revenue by Company (2019-2024)
2.3 Global Cryopreserved Hepatocytes Players Sales Volume Ranking (2023)
2.4 Global Cryopreserved Hepatocytes Sales Volume by Company Players (2019-2024)
2.5 Global Cryopreserved Hepatocytes Average Price by Company (2019-2024)
2.6 Key Manufacturers Cryopreserved Hepatocytes Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Cryopreserved Hepatocytes Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Cryopreserved Hepatocytes
2.9 Cryopreserved Hepatocytes Market Competitive Analysis
2.9.1 Cryopreserved Hepatocytes Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Cryopreserved Hepatocytes Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryopreserved Hepatocytes as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Hepatocytes
3.1.2 Animal Liver Cells
3.2 Global Cryopreserved Hepatocytes Sales Value by Type
3.2.1 Global Cryopreserved Hepatocytes Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Cryopreserved Hepatocytes Sales Value, by Type (2019-2030)
3.2.3 Global Cryopreserved Hepatocytes Sales Value, by Type (%) (2019-2030)
3.3 Global Cryopreserved Hepatocytes Sales Volume by Type
3.3.1 Global Cryopreserved Hepatocytes Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Cryopreserved Hepatocytes Sales Volume, by Type (2019-2030)
3.3.3 Global Cryopreserved Hepatocytes Sales Volume, by Type (%) (2019-2030)
3.4 Global Cryopreserved Hepatocytes Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cell/Molecular Biology
4.1.2 Virology
4.1.3 Other
4.2 Global Cryopreserved Hepatocytes Sales Value by Application
4.2.1 Global Cryopreserved Hepatocytes Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Cryopreserved Hepatocytes Sales Value, by Application (2019-2030)
4.2.3 Global Cryopreserved Hepatocytes Sales Value, by Application (%) (2019-2030)
4.3 Global Cryopreserved Hepatocytes Sales Volume by Application
4.3.1 Global Cryopreserved Hepatocytes Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Cryopreserved Hepatocytes Sales Volume, by Application (2019-2030)
4.3.3 Global Cryopreserved Hepatocytes Sales Volume, by Application (%) (2019-2030)
4.4 Global Cryopreserved Hepatocytes Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Cryopreserved Hepatocytes Sales Value by Region
5.1.1 Global Cryopreserved Hepatocytes Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Cryopreserved Hepatocytes Sales Value by Region (2019-2024)
5.1.3 Global Cryopreserved Hepatocytes Sales Value by Region (2025-2030)
5.1.4 Global Cryopreserved Hepatocytes Sales Value by Region (%), (2019-2030)
5.2 Global Cryopreserved Hepatocytes Sales Volume by Region
5.2.1 Global Cryopreserved Hepatocytes Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Cryopreserved Hepatocytes Sales Volume by Region (2019-2024)
5.2.3 Global Cryopreserved Hepatocytes Sales Volume by Region (2025-2030)
5.2.4 Global Cryopreserved Hepatocytes Sales Volume by Region (%), (2019-2030)
5.3 Global Cryopreserved Hepatocytes Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Cryopreserved Hepatocytes Sales Value, 2019-2030
5.4.2 North America Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Cryopreserved Hepatocytes Sales Value, 2019-2030
5.5.2 Europe Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Cryopreserved Hepatocytes Sales Value, 2019-2030
5.6.2 Asia Pacific Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Cryopreserved Hepatocytes Sales Value, 2019-2030
5.7.2 South America Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cryopreserved Hepatocytes Sales Value, 2019-2030
5.8.2 Middle East & Africa Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cryopreserved Hepatocytes Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Cryopreserved Hepatocytes Sales Value
6.2.1 Key Countries/Regions Cryopreserved Hepatocytes Sales Value, 2019-2030
6.2.2 Key Countries/Regions Cryopreserved Hepatocytes Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Cryopreserved Hepatocytes Sales Value, 2019-2030
6.3.2 United States Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Cryopreserved Hepatocytes Sales Value, 2019-2030
6.4.2 Europe Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Cryopreserved Hepatocytes Sales Value, 2019-2030
6.5.2 China Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.5.3 China Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Cryopreserved Hepatocytes Sales Value, 2019-2030
6.6.2 Japan Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Cryopreserved Hepatocytes Sales Value, 2019-2030
6.7.2 South Korea Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Cryopreserved Hepatocytes Sales Value, 2019-2030
6.8.2 Southeast Asia Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Cryopreserved Hepatocytes Sales Value, 2019-2030
6.9.2 India Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
6.9.3 India Cryopreserved Hepatocytes Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Corning
7.1.1 Corning Company Information
7.1.2 Corning Introduction and Business Overview
7.1.3 Corning Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Corning Cryopreserved Hepatocytes Product Offerings
7.1.5 Corning Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Introduction and Business Overview
7.2.3 Thermo Fisher Scientific Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Thermo Fisher Scientific Cryopreserved Hepatocytes Product Offerings
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Tocris Bioscience
7.3.1 Tocris Bioscience Company Information
7.3.2 Tocris Bioscience Introduction and Business Overview
7.3.3 Tocris Bioscience Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Tocris Bioscience Cryopreserved Hepatocytes Product Offerings
7.3.5 Tocris Bioscience Recent Development
7.4 LONZA
7.4.1 LONZA Company Information
7.4.2 LONZA Introduction and Business Overview
7.4.3 LONZA Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.4.4 LONZA Cryopreserved Hepatocytes Product Offerings
7.4.5 LONZA Recent Development
7.5 Cytes Biotechnologies
7.5.1 Cytes Biotechnologies Company Information
7.5.2 Cytes Biotechnologies Introduction and Business Overview
7.5.3 Cytes Biotechnologies Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Cytes Biotechnologies Cryopreserved Hepatocytes Product Offerings
7.5.5 Cytes Biotechnologies Recent Development
7.6 BioIVT
7.6.1 BioIVT Company Information
7.6.2 BioIVT Introduction and Business Overview
7.6.3 BioIVT Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.6.4 BioIVT Cryopreserved Hepatocytes Product Offerings
7.6.5 BioIVT Recent Development
7.7 XenoTech
7.7.1 XenoTech Company Information
7.7.2 XenoTech Introduction and Business Overview
7.7.3 XenoTech Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.7.4 XenoTech Cryopreserved Hepatocytes Product Offerings
7.7.5 XenoTech Recent Development
7.8 Sunncell
7.8.1 Sunncell Company Information
7.8.2 Sunncell Introduction and Business Overview
7.8.3 Sunncell Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Sunncell Cryopreserved Hepatocytes Product Offerings
7.8.5 Sunncell Recent Development
7.9 Atlantis Bioscience Pte Ltd
7.9.1 Atlantis Bioscience Pte Ltd Company Information
7.9.2 Atlantis Bioscience Pte Ltd Introduction and Business Overview
7.9.3 Atlantis Bioscience Pte Ltd Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Atlantis Bioscience Pte Ltd Cryopreserved Hepatocytes Product Offerings
7.9.5 Atlantis Bioscience Pte Ltd Recent Development
7.10 PRIMACYT Cell Culture Technology GmbH
7.10.1 PRIMACYT Cell Culture Technology GmbH Company Information
7.10.2 PRIMACYT Cell Culture Technology GmbH Introduction and Business Overview
7.10.3 PRIMACYT Cell Culture Technology GmbH Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.10.4 PRIMACYT Cell Culture Technology GmbH Cryopreserved Hepatocytes Product Offerings
7.10.5 PRIMACYT Cell Culture Technology GmbH Recent Development
7.11 Discovery
7.11.1 Discovery Company Information
7.11.2 Discovery Introduction and Business Overview
7.11.3 Discovery Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Discovery Cryopreserved Hepatocytes Product Offerings
7.11.5 Discovery Recent Development
7.12 MB Biosciences
7.12.1 MB Biosciences Company Information
7.12.2 MB Biosciences Introduction and Business Overview
7.12.3 MB Biosciences Cryopreserved Hepatocytes Sales, Revenue and Gross Margin (2019-2024)
7.12.4 MB Biosciences Cryopreserved Hepatocytes Product Offerings
7.12.5 MB Biosciences Recent Development
8 Industry Chain Analysis
8.1 Cryopreserved Hepatocytes Industrial Chain
8.2 Cryopreserved Hepatocytes Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Cryopreserved Hepatocytes Sales Model
8.5.2 Sales Channel
8.5.3 Cryopreserved Hepatocytes Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Cryopreserved Hepatocytes Market Trends
Table 2. Cryopreserved Hepatocytes Market Drivers & Opportunity
Table 3. Cryopreserved Hepatocytes Market Challenges
Table 4. Cryopreserved Hepatocytes Market Restraints
Table 5. Global Cryopreserved Hepatocytes Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Cryopreserved Hepatocytes Revenue Market Share by Company (2019-2024)
Table 7. Global Cryopreserved Hepatocytes Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Cryopreserved Hepatocytes Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Cryopreserved Hepatocytes Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Cryopreserved Hepatocytes Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Cryopreserved Hepatocytes Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Cryopreserved Hepatocytes
Table 13. Global Cryopreserved Hepatocytes Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryopreserved Hepatocytes as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Cryopreserved Hepatocytes Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Cryopreserved Hepatocytes Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Cryopreserved Hepatocytes Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Cryopreserved Hepatocytes Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Cryopreserved Hepatocytes Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Cryopreserved Hepatocytes Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Cryopreserved Hepatocytes Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Cryopreserved Hepatocytes Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Cryopreserved Hepatocytes Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Cryopreserved Hepatocytes Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Cryopreserved Hepatocytes Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Cryopreserved Hepatocytes Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Cryopreserved Hepatocytes Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Cryopreserved Hepatocytes Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Cryopreserved Hepatocytes Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Cryopreserved Hepatocytes Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Cryopreserved Hepatocytes Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Cryopreserved Hepatocytes Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Cryopreserved Hepatocytes Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Cryopreserved Hepatocytes Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Cryopreserved Hepatocytes Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Cryopreserved Hepatocytes Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Cryopreserved Hepatocytes Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Cryopreserved Hepatocytes Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Cryopreserved Hepatocytes Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Cryopreserved Hepatocytes Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Cryopreserved Hepatocytes Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Cryopreserved Hepatocytes Sales Value by Region (2019-2024) & (%)
Table 44. Global Cryopreserved Hepatocytes Sales Value by Region (2025-2030) & (%)
Table 45. Global Cryopreserved Hepatocytes Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Cryopreserved Hepatocytes Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Cryopreserved Hepatocytes Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Cryopreserved Hepatocytes Sales Volume by Region (2019-2024) & (%)
Table 49. Global Cryopreserved Hepatocytes Sales Volume by Region (2025-2030) & (%)
Table 50. Global Cryopreserved Hepatocytes Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Cryopreserved Hepatocytes Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Cryopreserved Hepatocytes Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Cryopreserved Hepatocytes Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Cryopreserved Hepatocytes Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Cryopreserved Hepatocytes Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Cryopreserved Hepatocytes Sales Volume, (2025-2030) & (K Units)
Table 57. Corning Company Information
Table 58. Corning Introduction and Business Overview
Table 59. Corning Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Corning Cryopreserved Hepatocytes Product Offerings
Table 61. Corning Recent Development
Table 62. Thermo Fisher Scientific Company Information
Table 63. Thermo Fisher Scientific Introduction and Business Overview
Table 64. Thermo Fisher Scientific Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Thermo Fisher Scientific Cryopreserved Hepatocytes Product Offerings
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Tocris Bioscience Company Information
Table 68. Tocris Bioscience Introduction and Business Overview
Table 69. Tocris Bioscience Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Tocris Bioscience Cryopreserved Hepatocytes Product Offerings
Table 71. Tocris Bioscience Recent Development
Table 72. LONZA Company Information
Table 73. LONZA Introduction and Business Overview
Table 74. LONZA Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. LONZA Cryopreserved Hepatocytes Product Offerings
Table 76. LONZA Recent Development
Table 77. Cytes Biotechnologies Company Information
Table 78. Cytes Biotechnologies Introduction and Business Overview
Table 79. Cytes Biotechnologies Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Cytes Biotechnologies Cryopreserved Hepatocytes Product Offerings
Table 81. Cytes Biotechnologies Recent Development
Table 82. BioIVT Company Information
Table 83. BioIVT Introduction and Business Overview
Table 84. BioIVT Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. BioIVT Cryopreserved Hepatocytes Product Offerings
Table 86. BioIVT Recent Development
Table 87. XenoTech Company Information
Table 88. XenoTech Introduction and Business Overview
Table 89. XenoTech Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. XenoTech Cryopreserved Hepatocytes Product Offerings
Table 91. XenoTech Recent Development
Table 92. Sunncell Company Information
Table 93. Sunncell Introduction and Business Overview
Table 94. Sunncell Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Sunncell Cryopreserved Hepatocytes Product Offerings
Table 96. Sunncell Recent Development
Table 97. Atlantis Bioscience Pte Ltd Company Information
Table 98. Atlantis Bioscience Pte Ltd Introduction and Business Overview
Table 99. Atlantis Bioscience Pte Ltd Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Atlantis Bioscience Pte Ltd Cryopreserved Hepatocytes Product Offerings
Table 101. Atlantis Bioscience Pte Ltd Recent Development
Table 102. PRIMACYT Cell Culture Technology GmbH Company Information
Table 103. PRIMACYT Cell Culture Technology GmbH Introduction and Business Overview
Table 104. PRIMACYT Cell Culture Technology GmbH Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. PRIMACYT Cell Culture Technology GmbH Cryopreserved Hepatocytes Product Offerings
Table 106. PRIMACYT Cell Culture Technology GmbH Recent Development
Table 107. Discovery Company Information
Table 108. Discovery Introduction and Business Overview
Table 109. Discovery Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Discovery Cryopreserved Hepatocytes Product Offerings
Table 111. Discovery Recent Development
Table 112. MB Biosciences Company Information
Table 113. MB Biosciences Introduction and Business Overview
Table 114. MB Biosciences Cryopreserved Hepatocytes Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. MB Biosciences Cryopreserved Hepatocytes Product Offerings
Table 116. MB Biosciences Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Cryopreserved Hepatocytes Downstream Customers
Table 120. Cryopreserved Hepatocytes Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Cryopreserved Hepatocytes Product Picture
Figure 2. Global Cryopreserved Hepatocytes Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Cryopreserved Hepatocytes Sales Volume (2019-2030) & (K Units)
Figure 5. Global Cryopreserved Hepatocytes Sales Price (2019-2030) & (US$/Unit)
Figure 6. Cryopreserved Hepatocytes Report Years Considered
Figure 7. Global Cryopreserved Hepatocytes Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Cryopreserved Hepatocytes Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cryopreserved Hepatocytes Revenue in 2023
Figure 10. Cryopreserved Hepatocytes Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Human Hepatocytes Picture
Figure 12. Animal Liver Cells Picture
Figure 13. Global Cryopreserved Hepatocytes Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Cryopreserved Hepatocytes Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Cryopreserved Hepatocytes Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Cryopreserved Hepatocytes Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Cryopreserved Hepatocytes Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Cell/Molecular Biology
Figure 19. Product Picture of Virology
Figure 20. Product Picture of Other
Figure 21. Global Cryopreserved Hepatocytes Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Cryopreserved Hepatocytes Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Cryopreserved Hepatocytes Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Cryopreserved Hepatocytes Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Cryopreserved Hepatocytes Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Cryopreserved Hepatocytes Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Cryopreserved Hepatocytes Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Cryopreserved Hepatocytes Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Cryopreserved Hepatocytes Sales Volume (%), (2019-2030)
Figure 38. United States Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 44. China Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 46. China Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 56. India Cryopreserved Hepatocytes Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Cryopreserved Hepatocytes Sales Value by Type (%), 2023 VS 2030
Figure 58. India Cryopreserved Hepatocytes Sales Value by Application (%), 2023 VS 2030
Figure 59. Cryopreserved Hepatocytes Industrial Chain
Figure 60. Cryopreserved Hepatocytes Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
